This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maw, M. A. Articles by Reeve, A. E. Search for Related Content PubMed PubMed Citation Articles by Maw, M. A. Articles by Reeve, A. E.

A Third Wilms' Tumor Locus on Chromosome 16q¹

Molecular Carcinogenesis Laboratory, Department of Biochemistry, University of Otago, P. O. Box 56, Dunedin, New Zealand [M. A. M., L. J. M., M. R. E., A. E. R.]; Departments of Pediatrics and Medicine, Cross Cancer Institute and Faculty of Medicine, University of Alberta, Edmonton, Alberta, T6G 1Z2 Canada [P. E. G., M. C. P., P. E. T.]; Department of Pathology, University of Queensland, Herston, Queensland, Australia 4006 [R. S. D., P. J. S.]; Howard Hughes Medical Institute and Departments of Internal Medicine and Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan 48109-0650 [A. P. F., D. J. L.]; and Department of Cytogenetics and Molecular Genetics, Adelaide Children's Hospital, North Adelaide, South Australia, 5006 [D. F. C., A. D. T., R. I. R.]

Loss of heterozygosity studies have been used to identify chromosomal regions which are frequently deleted and thus indicate areas which may harbor tumor suppressor genes. As a result, both the WT1 gene located in chromosome 11p13 and an unidentified gene(s) within chromosome 11p15 have been implicated in Wilms' tumorigenesis. Cytogenetic and linkage studies suggest that additional non-chromosome 11 sites are involved in Wilms' tumor. Because these sites may also involve loss of heterozygosity, loci on 33 autosomal arms were screened for allele loss in a series of Wilms' tumors. We found that in addition to loss on chromosome 11p (11 of 25 informative tumors) there was significant loss on chromosome 16q (9 of 45 informative tumors), while the total frequency of allele loss excluding these loci was low (9 of 426 total informative loci). These data indicate that losses of both chromosome 11p and 16q alleles are nonrandom events and suggest that 16q is the location of a third tumor suppressor gene underlying Wilms' tumorigenesis. The parental origin of the lost chromosome 16q allele was determined in eight sporadic tumors. Alleles of paternal and of maternal origin were each lost in four sporadic tumors indicating that, unlike chromosome 11p, alleles of either parental origin are lost on 16q.

¹ This work was supported by the Cancer Society of New Zealand, Alberta Heritage Foundation for Medical Research, Medical Research Council of Canada, Howard Hughes Medical Institute, and the Queensland Cancer Fund.

² To whom requests for reprints should be addressed.

Received 10/16/91. Accepted 3/25/92.

This article has been cited by other articles:

				S. D. Safford, D. Goyeau, A. J. Freemerman, R. Bentley, M. L. Everett, P. E. Grundy, and M. A. Skinner Fine Mapping of Wilms' Tumors With 16q Loss of Heterozygosity Localizes the Putative Tumor Suppressor Gene to a Region of 6.7 Megabases Ann. Surg. Oncol., March 1, 2003; 10(2): 136 - 143. [Abstract] [Full Text] [PDF]

				T. Ishizaki, M. Yoshie, Y. Yaginuma, T. Tanaka, and K. Ogawa Loss of Igf2 Imprinting in Monoclonal Mouse Hepatic Tumor Cells Is Not Associated with Abnormal Methylation Patterns for the H19, Igf2, and Kvlqt1 Differentially Methylated Regions J. Biol. Chem., February 14, 2003; 278(8): 6222 - 6228. [Abstract] [Full Text] [PDF]

				G. N. Filippova, C.-F. Qi, J. E. Ulmer, J. M. Moore, M. D. Ward, Y. J. Hu, D. I. Loukinov, E. M. Pugacheva, E. M. Klenova, P. E. Grundy, et al. Tumor-associated Zinc Finger Mutations in the CTCF Transcription Factor Selectively Alter Its DNA-binding Specificity Cancer Res., January 1, 2002; 62(1): 48 - 52. [Abstract] [Full Text] [PDF]

				J. D. Ravenel, K. W. Broman, E. J. Perlman, E. L. Niemitz, T. M. Jayawardena, D. W. Bell, D. A. Haber, H. Uejima, and A. P. Feinberg Loss of Imprinting of Insulin-Like Growth Factor-II (IGF2) Gene in Distinguishing Specific Biologic Subtypes of Wilms Tumor J Natl Cancer Inst, November 21, 2001; 93(22): 1698 - 1703. [Abstract] [Full Text] [PDF]

				H. Cui, E. L. Niemitz, J. D. Ravenel, P. Onyango, S. A. Brandenburg, V. V. Lobanenkov, and A. P. Feinberg Loss of Imprinting of Insulin-like Growth Factor-II in Wilms' Tumor Commonly Involves Altered Methylation but not Mutations of CTCF or Its Binding Site Cancer Res., July 1, 2001; 61(13): 4947 - 4950. [Abstract] [Full Text] [PDF]

				P. L. Paris, J. S. Witte, P. A. Kupelian, H. Levin, E. A. Klein, W. J. Catalona, and G. Casey Identification and Fine Mapping of a Region Showing a High Frequency of Allelic Imbalance on Chromosome 16q23.2 That Corresponds to a Prostate Cancer Susceptibility Locus Cancer Res., July 1, 2000; 60(13): 3645 - 3649. [Abstract] [Full Text]

				S. Hosono, I. Gross, M. A. English, K. M. Hajra, E. R. Fearon, and J. D. Licht E-cadherin Is a WT1 Target Gene J. Biol. Chem., April 6, 2000; 275(15): 10943 - 10953. [Abstract] [Full Text] [PDF]

				M. Mangelsdorf, K. Ried, E. Woollatt, S. Dayan, H. Eyre, M. Finnis, L. Hobson, J. Nancarrow, D. Venter, E. Baker, et al. Chromosomal Fragile Site FRA16D and DNA Instability in Cancer Cancer Res., March 1, 2000; 60(6): 1683 - 1689. [Abstract] [Full Text]

				R. Koesters, R. Ridder, A. Kopp-Schneider, D. Betts, V. Adams, F. Niggli, J. Briner, and M. v. K. Doeberitz Mutational Activation of the {beta}-Catenin Proto-Oncogene Is a Common Event in the Development of Wilms' Tumors Cancer Res., August 1, 1999; 59(16): 3880 - 3882. [Abstract] [Full Text] [PDF]

				A. K. Charles, K. W. Brown, and P. J. Berry Microdissecting the Genetic Events in Nephrogenic Rests and Wilms' Tumor Development Am. J. Pathol., September 1, 1998; 153(3): 991 - 1000. [Abstract] [Full Text] [PDF]

				M. J. Coppes, D. A. Haber, and P. E. Grundy Genetic Events in the Development of Wilms' Tumor N. Engl. J. Med., September 1, 1994; 331(9): 586 - 590. [Full Text]

				G J Hannon, D Demetrick, and D Beach Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes & Dev., December 1, 1993; 7(12a): 2378 - 2391. [Abstract] [PDF]